Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousFetal BloodGraft vs Host DiseaseTransplantation ConditioningStem CellsBone Marrow TransplantationStem Cell TransplantationHematopoietic Stem CellsHematopoietic Stem Cell MobilizationImmunosuppressive AgentsSpinal CordTreatment OutcomeHematologic NeoplasmsAntigens, CD34Cord Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorGraft SurvivalLeukapheresisSpinal Cord InjuriesTissue DonorsTransplantationHistocompatibility TestingBlood Component RemovalCytomegalovirus InfectionsEmbryonic Stem CellsHistocompatibilityUmbilical CordMelphalanCombined Modality TherapyAdult Stem CellsImmunocompromised HostBlood BanksBusulfanMultiple MyelomaCell DifferentiationTime FactorsRecurrenceTransplantation ChimeraRetrospective StudiesOpportunistic InfectionsCyclophosphamidePluripotent Stem CellsInfant, NewbornAntineoplastic Combined Chemotherapy ProtocolsLeukemiaWhole-Body IrradiationHematopoiesisBlood CellsMyeloablative AgonistsCells, CulturedHematologic DiseasesStem Cell FactorRoseolovirus InfectionsBlood Cell CountStem Cell NicheFlow CytometryCell SeparationTransplantsInduced Pluripotent Stem CellsMesenchymal Stem Cell TransplantationCytomegalovirusKidney TransplantationCell LineageNeural Stem CellsRemission InductionBone Marrow CellsMycosesLymphoma, Non-HodgkinSurvival RateColony-Forming Units AssaySalvage TherapyAspergillosisBlood DonorsAnemia, AplasticMesenchymal Stromal CellsSurvival AnalysisFatal OutcomeInfectionMultipotent Stem CellsVidarabineDisease-Free SurvivalLeukemia, Myeloid, AcuteImmunophenotypingPregnancyFollow-Up StudiesHLA AntigensProspective StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaCell Culture TechniquesCyclosporineBone Marrow PurgingAcute DiseaseHepatic Veno-Occlusive DiseaseAntigens, CDMice, SCIDNeoplasms